Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,276,762 papers from all fields of science
Search
Sign In
Create Free Account
9p22.2
A chromosome band present on 9p
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
3 relations
Chromosome 9 Short Arm
Chromosomes
PSIP1 wt Allele
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Functional Analysis and Fine Mapping of the 9p22.2 Ovarian Cancer Susceptibility Locus.
Melissa Buckley
,
Nicholas T. Woods
,
+24 authors
A. Monteiro
Cancer Research
2018
Corpus ID: 54109772
Genome-wide association studies have identified 40 ovarian cancer risk loci. However, the mechanisms underlying these…
Expand
2018
2018
An international meta-analysis confirms the association of BNC2 with adolescent idiopathic scoliosis
Y. Ogura
,
K. Takeda
,
+22 authors
S. Ikegawa
Scientific Reports
2018
Corpus ID: 3909920
Adolescent idiopathic scoliosis (AIS) is a common spinal deformity with the prevalence of approximately 3%. We previously…
Expand
Highly Cited
2016
Highly Cited
2016
Metastatic basal cell carcinoma with amplification of PD-L1: exceptional response to anti-PD1 therapy
S. Ikeda
,
A. Goodman
,
+6 authors
R. Kurzrock
npj Genomic Medicine
2016
Corpus ID: 10916639
Metastatic basal cell carcinomas are rare malignancies harbouring Hedgehog pathway alterations targetable by SMO antagonists…
Expand
Review
2011
Review
2011
Genetic susceptibility to sporadic ovarian cancer: a systematic review.
M. Braem
,
L. J. Schouten
,
P. Peeters
,
P. A. V. D. Brandt
,
N. Onland-Moret
Biochimica et Biophysica Acta
2011
Corpus ID: 12763105
Highly Cited
2011
Highly Cited
2011
Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers.
S. Ramus
,
C. Kartsonaki
,
+150 authors
A. Antoniou
Journal of the National Cancer Institute
2011
Corpus ID: 13793217
BACKGROUND Germline mutations in the BRCA1 and BRCA2 genes are associated with increased risks of breast and ovarian cancers…
Expand
2010
2010
A Genome-Wide Association Study Identifies A New Ovarian Cancer Susceptibility Locus On 9 p 22 . 2
Honglin Song
,
S. Ramus
,
+100 authors
S. Gayther
2010
Corpus ID: 115137738
Epithelial ovarian cancer has a major heritable component, but the known susceptibility genes explain less than half the excess…
Expand
2010
2010
A de novo marker chromosome derived from 9p in a patient with 9p partial duplication syndrome and autism features: genotype-phenotype correlation
K. Abu-Amero
,
A. Hellani
,
+4 authors
T. Bosley
BMC Medical Genetics
2010
Corpus ID: 8053713
BackgroundPrevious studies focusing on candidate genes and chromosomal regions identified several copy number variations (CNVs…
Expand
2009
2009
A Gynecologic Oncology Group study of frequent copy number aberrations in DNA repair genes and other genomic regions in stage I serous ovarian cancers.
T. Pejovic
,
D. Gaile
,
+7 authors
N. Nowak
Journal of Clinical Oncology
2009
Corpus ID: 36975594
e16504 Background: A proof of principle array-based comparative genomic hybridization (aCGH) analysis was performed in archival…
Expand
2009
2009
Potential predictive markers of chemotherapy resistance in stage III ovarian serous carcinomas
L. Österberg
,
K. Levan
,
+4 authors
G. Horvath
BMC Cancer
2009
Corpus ID: 16890185
BackgroundChemotherapy resistance remains a major obstacle in the treatment of women with ovarian cancer. Establishing predictive…
Expand
2007
2007
Novel aphidicolin‐inducible common fragile site FRA9G maps to 9p22.2, within the C9orf39 gene
M. Sawińska
,
Jens Guido Schmitt
,
E. Sagulenko
,
F. Westermann
,
M. Schwab
,
L. Savelyeva
Genes, Chromosomes and Cancer
2007
Corpus ID: 25292068
Common fragile sites represent a component of normal chromosome structure that form gaps and breaks on metaphase chromosomes…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE